A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability
- PMID: 29936235
- DOI: 10.1016/j.nbd.2018.06.012
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability
Abstract
The causes of genetic epilepsies are unknown in the majority of patients. HCN ion channels have a widespread expression in neurons and increasing evidence demonstrates their functional involvement in human epilepsies. Among the four known isoforms, HCN1 is the most expressed in the neocortex and hippocampus and de novo HCN1 point mutations have been recently associated with early infantile epileptic encephalopathy. So far, HCN1 mutations have not been reported in patients with idiopathic epilepsy. Using a Next Generation Sequencing approach, we identified the de novo heterozygous p.Leu157Val (c.469C > G) novel mutation in HCN1 in an adult male patient affected by genetic generalized epilepsy (GGE), with normal cognitive development. Electrophysiological analysis in heterologous expression model (CHO cells) and in neurons revealed that L157V is a loss-of-function, dominant negative mutation causing reduced HCN1 contribution to net inward current and responsible for an increased neuronal firing rate and excitability, potentially predisposing to epilepsy. These data represent the first evidence that autosomal dominant missense mutations of HCN1 can also be involved in GGE, without the characteristics of epileptic encephalopathy reported previously. It will be important to include HCN1 screening in patients with GGE, in order to extend the knowledge of the genetic causes of idiopathic epilepsies, thus paving the way for the identification of innovative therapeutic strategies.
Keywords: Electrophysiology; Genetic generalized epilepsy; HCN1; Membrane excitability.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.Brain. 2018 Nov 1;141(11):3160-3178. doi: 10.1093/brain/awy263. Brain. 2018. PMID: 30351409
-
De novo mutations in HCN1 cause early infantile epileptic encephalopathy.Nat Genet. 2014 Jun;46(6):640-5. doi: 10.1038/ng.2952. Epub 2014 Apr 20. Nat Genet. 2014. PMID: 24747641
-
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy.J Neurosci. 2011 Nov 30;31(48):17327-37. doi: 10.1523/JNEUROSCI.3727-11.2011. J Neurosci. 2011. PMID: 22131395 Free PMC article.
-
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature.Epilepsy Res. 2019 Jul;153:49-58. doi: 10.1016/j.eplepsyres.2019.04.004. Epub 2019 Apr 8. Epilepsy Res. 2019. PMID: 30986657 Review.
-
The Impact of Altered HCN1 Expression on Brain Function and Its Relationship with Epileptogenesis.Curr Neuropharmacol. 2023;21(10):2070-2078. doi: 10.2174/1570159X21666230214110333. Curr Neuropharmacol. 2023. PMID: 37366350 Free PMC article. Review.
Cited by
-
Activation of metabotropic glutamate receptor 1 regulates hippocampal CA1 region excitability in rats with status epilepticus by suppressing the HCN1 channel.Neural Regen Res. 2023 Mar;18(3):594-602. doi: 10.4103/1673-5374.350206. Neural Regen Res. 2023. PMID: 36018183 Free PMC article.
-
Identification of HCN1 as a 14-3-3 client.PLoS One. 2022 Jun 9;17(6):e0268335. doi: 10.1371/journal.pone.0268335. eCollection 2022. PLoS One. 2022. PMID: 35679272 Free PMC article.
-
The HCN1 p.Ser399Pro variant causes epileptic encephalopathy with super-refractory status epilepticus.Hum Genome Var. 2023 Jun 23;10(1):20. doi: 10.1038/s41439-023-00247-8. Hum Genome Var. 2023. PMID: 37353494 Free PMC article.
-
Seizures, behavioral deficits, and adverse drug responses in two new genetic mouse models of HCN1 epileptic encephalopathy.Elife. 2022 Aug 16;11:e70826. doi: 10.7554/eLife.70826. Elife. 2022. PMID: 35972069 Free PMC article.
-
The Contribution of HCN Channelopathies in Different Epileptic Syndromes, Mechanisms, Modulators, and Potential Treatment Targets: A Systematic Review.Front Mol Neurosci. 2022 May 19;15:807202. doi: 10.3389/fnmol.2022.807202. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35663267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases